DBV Technologies S.A. - American Depositary Shares (DBVT)
4.2000
-0.0600 (-1.41%)
Dbv Technologies is a biopharmaceutical company focused on developing innovative therapies for patients with food allergies, particularly peanut allergies
Utilizing its proprietary Systemic Immunotherapy platform, the company aims to create treatments that help desensitize individuals to allergens, ultimately enhancing their quality of life and reducing the risk of severe allergic reactions. By leveraging advanced medical technology and a rigorous clinical development approach, Dbv Technologies strives to bring novel, breakthrough solutions to the field of immunotherapy for food allergies.
Frequently Asked Questions
Is DBV Technologies S.A. - American Depositary Shares publicly traded?
Yes, DBV Technologies S.A. - American Depositary Shares is publicly traded.
What exchange does DBV Technologies S.A. - American Depositary Shares trade on?
DBV Technologies S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for DBV Technologies S.A. - American Depositary Shares?
The ticker symbol for DBV Technologies S.A. - American Depositary Shares is DBVT on the Nasdaq Stock Market
What is the current price of DBV Technologies S.A. - American Depositary Shares?
The current price of DBV Technologies S.A. - American Depositary Shares is 4.200
When was DBV Technologies S.A. - American Depositary Shares last traded?
The last trade of DBV Technologies S.A. - American Depositary Shares was at 12:05 pm EST on January 31st, 2025
What is the market capitalization of DBV Technologies S.A. - American Depositary Shares?
The market capitalization of DBV Technologies S.A. - American Depositary Shares is 231.41M
How many shares of DBV Technologies S.A. - American Depositary Shares are outstanding?
DBV Technologies S.A. - American Depositary Shares has 55.10M shares outstanding.